miR-145 inhibits breast cancer cell growth through RTKN.

Shihua Wang(Shanghai Library), Robert Chunhua Zhao(Shanghai University), Hong Zhou(Anhui Medical University), Jing Li(Guiyang College of Traditional Chinese Medicine), Ye Bo, Lifen Zeng, Chunjing Bian(Chinese Academy of Medical Sciences & Peking Union Medical College), Zhuo Yang(Chinese Center For Disease Control and Prevention)
PubMed
May 1, 2009
Cited by 164

Related Papers

Epigenetic memory in induced pluripotent stem cells
|Nature|2010|2.3k
Incidence of Venous Thromboembolism and Its Effect on Survival Among Patients With Common Cancers
|Archives of Internal Medicine|2006|1.3k
Incidence and Time Course of Thromboembolic Outcomes Following Total Hip or Knee Arthroplasty
|Archives of Internal Medicine|1998|598
Venous Thromboembolism in Patients With Colorectal Cancer: Incidence and Effect on Survival
|Journal of Clinical Oncology|2006|366
The Incidence and Case-fatality Rates of Acute Biliary, Alcoholic, and Idiopathic Pancreatitis in California, 1994-2001
|Pancreas|2006|316